Fabrizio Calisti Selected Research

Fabrizio Calisti Research Topics

4	Sleep Initiation and Maintenance Disorders (Insomnia) 01/2022 - 01/2018
3	Schizophrenia (Dementia Praecox) 01/2022 - 01/2021
2	Nausea 01/2022 - 10/2021
2	Psychomotor Agitation (Akathisia) 01/2022 - 10/2021
2	Weight Gain 10/2021 - 01/2021
1	Parkinsonian Disorders (Parkinsonism) 01/2022
1	Headache (Headaches) 01/2022
1	Sleepiness 10/2021
1	Patent Ductus Arteriosus 03/2021
1	Chronic Bronchitis 01/2021
1	Body Weight (Weight, Body) 01/2021
1	Weight Loss (Weight Reduction) 01/2021
1	Diabetic Neuropathies (Diabetic Neuropathy) 11/2020
1	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 01/2018

3	Lurasidone Hydrochloride FDA Link 01/2022 - 01/2021
3	Trazodone (Trittico)FDA LinkGeneric 01/2022 - 01/2020
1	Ibuprofen (Motrin)FDA LinkGeneric 03/2021
1	Acetaminophen (Paracetamol)FDA LinkGeneric 03/2021
1	vasectrin I (VS I)IBA 03/2021
1	prulifloxacinIBA 01/2021
1	ziprasidone (Geodon)FDA Link 01/2021
1	Aripiprazole (Abilify)FDA Link 01/2021
1	Paliperidone Palmitate FDA Link 01/2021
1	Quetiapine Fumarate (Seroquel)FDA Link 01/2021
1	Olanzapine (Zyprexa)FDA Link 01/2021
1	Clozapine (Clozaril)FDA LinkGeneric 01/2021
1	Antipsychotic Agents (Antipsychotics)IBA 01/2021
1	Risperidone (Risperdal Consta)FDA LinkGeneric 01/2021
1	Gabapentin (Neurontin)FDA LinkGeneric 11/2020
1	Analgesics (Analgesic Drugs)IBA 11/2020
1	Atomoxetine Hydrochloride (Strattera)FDA LinkGeneric 01/2020
1	BenzodiazepinesIBA 01/2018
1	Tricyclic Antidepressive Agents (Tricyclic Antidepressants)IBA 01/2018
1	Clonidine (ST 155)FDA LinkGeneric 01/2018